Analyst Alerts: Newell, Incyte, Intel, Medivation, Alcatel-Lucent May 23rd
Intel Corporation (NASDAQ:INTC): JPMorgan views Dell’s (NASDAQ:DELL) results and guidance as a negative data point for Intel (NASDAQ:INTC) and reiterates a Neutral rating on shares of Intel. The firm points out Dell indicated that PC demand is slowing, tablets and smartphones are cannibalizing notebook sales, and that customers are delaying spending on information technology.
Newell Rubbermaid Inc. (NYSE:NWL): RBC Capital expects Newell to give investors more insight into its growth strategy during its Analyst Day tomorrow. The firm expects investors to become more comfortable with the company’s strategy following the Analyst Day and it maintains a $23 target and Outperform rating.
Incyte Corporation (NASDAQ:INCY): Morgan Stanley said current consensus estimates do not reflect myelofibrosis competition, which could impact Incyte’s Jakafi sales. Shares are Equal Weight rated.
Medivation, Inc. (NASDAQ:MDVN): Credit Suisse said ‘302 data provides support for PREVAL success. Shares are Outperform rated.
Alcatel-Lucent (NYSE:ALU): After Alcatel-Lucent announced that it’s entering the core router market, BMO Capital believes that the company could take a meaningful share of the market over time, and the firm views the move as positive. It thinks that the stock is materially undervalued and reiterates an Outperform rating.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.